Chinese companies are pivoting from broad AI models to specialized artificial intelligence applications to drive revenue growth, with Alibaba and MagicPen Bio exemplifying this new phase.
The New Focus in China's AI Race
- After matching U.S. peers in general AI chatbots, Chinese firms are now prioritizing industry-specific AI for monetization.
- Executives emphasize that large language models like DeepSeek alone are insufficient for sustainable business income.
Alibaba's AI-Powered Accio Work
- Alibaba.com upgraded its Accio sourcing platform with AI to automate customs paperwork, calculate profit margins, and enable product customization searches.
- President Kuo Zhang stated the tool helps businesses navigate tariff volatility and aims to expand monthly active users from millions to tens of millions by next year.
- The company plans partnerships with U.S. AI models to handle country-specific legal, financial, and HR regulations for global entrepreneurs.
MagicPen Bio's Glow-in-the-Dark Innovation
- Startup MagicPen Bio uses AI-driven research to fuse firefly and fungi luminescence with plants, creating eco-friendly lighting solutions.
- Founder Li Renhan forecasts 200 million yuan ($28.94 million) in global revenue this year, focusing on selling patented technology rather than exporting plants.
- The firm, holding about 20 patents, is finalizing partnerships in the U.S. and Middle East for local sales and distribution.
Global Market Expansion
- Both Alibaba and MagicPen Bio are targeting international markets, especially the U.S. and Middle East, to scale revenue through partnerships and technology licensing.
- This trend reflects a strategic shift among Chinese businesses toward specialized AI for cross-border growth and regulatory adaptation.